drugset
Drugs / recombinant human interleukin
last change Aug 2025 re-read 2 minutes ago

recombinant human interleukin

English name Interleukin 2

Protein / enzyme biologic

Developed for
multidrug-resistant tuberculosis
Investigated by
Huashan Hospital · No.85 Hospital, Changning, Shanghai, China · Shanghai Public Health Clinical Center · Shanghai Pulmonary Hospital, Shanghai, China

Trials 1 · a red edge is where a trial was stopped

today NCT05493267 · Ph 4
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05493267 Aug 2022 → Aug 2025 overdue multidrug-resistant tuberculosis Shanghai Pulmonary Hospital, Shanghai, China Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as recombinant human interleukin “a subcutaneous injection recombinant human interleukin” NCT05493267 ↗
Modality Protein / enzyme biologic “recombinant human interleukin” NCT05493267 ↗
Route Subcutaneous “a subcutaneous injection recombinant human interleukin” NCT05493267 ↗